Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 3rd quarter

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon Jun 27, 2024 10:24am

150 Views

Post# 36108797

RE:RE:RE:RE:RE:RE:RE:RE:3rd quarter

@wildbird: You missed the point, as usual. If 3 years ago, TLT didn't have all these things, why were you still saying BTD is right around the corner, no more money needed, we should expect a buyout or JV? So the ask was, switch gears to posting useful links. Some of us have been holding longer than you.. I have half a mind to put you on ignore.

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading